Certain cell lines derived from lymphoid tumors display high sensitivity to direct (single agent) Chk1 inhibition [14], and this particularly concerns lymphoma cells in which c-Myc oncoprotein drives proliferation [15, 16]. This evidence concerns the gene CHEK1 and lymphoid neoplasm.